Organovo Holdings, Inc. ( ONVO) - Key Metrics
Stock symbol ONVO is outdated, potentially delisted? Maybe it is available on other exchange?
ONVO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0 | -$0.19 | -$0.10 | -$0.10 |
| 2024Q2 | $0 | -$0.14 | -$0.15 | -$0.15 |
| 2024Q1 | $0 | -$0.23 | -$0.20 | -$0.20 |
| 2023Q4 | $0 | -$0.30 | -$0.27 | -$0.27 |
| 2023Q3 | $0 | -$0.40 | -$0.39 | -$0.39 |
ONVO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -0.60 |
| 2024Q2 | ? | -0.90 |
| 2024Q1 | ? | -0.83 |
| 2023Q4 | ? | -0.85 |
| 2023Q3 | ? | -0.70 |
ONVO
Price: $2.04
52 week price:
Earnings Per Share: -10.08 USD
P/E Ratio: -0.22
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 21800
Ebitda: -7.6 millionMarket Capitalization: 3.7 million